Cancer Risk Software
-
based in USA
cancer depends on the ability to characterize genes and alterations associated with increased cancer risk accurately. Next-generation sequencing (NGS) is transforming the way genomic evaluation of hereditary cancers is performed and integrated into the daily workflow of clinical ...
-
based in USA
PenRad’s PenGen system allows facilities to collect and manage patients’ risk assessments and genetic testing eligibility. System calculates real-time cancer risk scores, and Genetic testing eligibility based on multiple models, for patient and ...
-
Manufactured by CMR Naviscan Corporationbased in USA
A New Standard of Care in Early Breast Cancer Detection. Even when a mammogram is deemed negative, additional adjunctive tests, such as Molecular Breast Imaging (MBI), for women with dense breast tissue or who are considered high-risk for breast cancer should be considered. When a patient is determined to have dense breast tissue, or ...
-
by Arterys Inc.based in USA
Breast AI provides innovative solutions for breast cancer detection, measure breast density and assess personalized risk that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you